We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.12%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$331B
AUM Growth
+$5.64B
Cap. Flow
-$2.7B
Cap. Flow %
-0.81%
Top 10 Hldgs %
12.38%
Holding
6,874
New
204
Increased
2,959
Reduced
3,018
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 9.92%
2 Financials 9.63%
3 Healthcare 8.27%
4 Consumer Discretionary 7.53%
5 Communication Services 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXBR icon
5876
Oxbridge Re Holdings
OXBR
$10.6M
$23K ﹤0.01%
4,100
PAMT
5877
PAMT Corp
PAMT
$338M
$23K ﹤0.01%
4,780
-9,088
-66% -$39.4K
CEL
5878
DELISTED
Cellcom Israel, Ltd.
CEL
$23K ﹤0.01%
2,336
+100
+4% +$988
EDGW
5879
DELISTED
Edgewater Technology Inc
EDGW
$23K ﹤0.01%
3,359
-30,141
-90% -$216K
OCRX
5880
DELISTED
Ocera Therapeutics, Inc.
OCRX
$23K ﹤0.01%
19,366
-7,798
-29% -$9.06K
SGB
5881
DELISTED
Southwest Georgia Financial Corporation
SGB
$23K ﹤0.01%
1,167
-192
-14% -$3.93K
CANF
5882
Can-Fite BioPharma American Depositary Shares
CANF
$7.03M
$22K ﹤0.01%
+4
New +$22K
FCAP icon
5883
First Capital
FCAP
$212M
$22K ﹤0.01%
725
+8
+1% +$252
TNXP icon
5884
Tonix Pharmaceuticals
TNXP
$160M
0
CGRN
5885
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$22K ﹤0.01%
3,198
+60
+2% +$422
EGIF
5886
DELISTED
Eagle Growth and Income Opportunities Fund
EGIF
$22K ﹤0.01%
1,250
-1,107
-47% -$19K
SUMR
5887
DELISTED
Summer Infant, Inc.
SUMR
$22K ﹤0.01%
1,368
+12
+0.9% +$196
PERM
5888
DELISTED
Global X Permanent ETF
PERM
$22K ﹤0.01%
859
APYX icon
5889
Apyx Medical
APYX
$173M
$21K ﹤0.01%
8,683
-1,212
-12% -$2.98K
AXIA.PR
5890
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
$21K ﹤0.01%
4,179
-42,379
-91% -$246K
MBRX icon
5891
Moleculin Biotech
MBRX
$2.83M
$21K ﹤0.01%
5
OEFA
5892
ALPS O'Shares International Developed Quality Dividend ETF
OEFA
$36.5M
$21K ﹤0.01%
864
OTLK icon
5893
Outlook Therapeutics
OTLK
$183M
$21K ﹤0.01%
133
SHIP icon
5894
Seanergy Maritime Holdings
SHIP
$379M
$21K ﹤0.01%
+9
New +$16.9K
TTT icon
5895
ProShares UltraPro Short 20+ Year Treasury
TTT
$19.5M
$21K ﹤0.01%
200
VSTM icon
5896
Verastem
VSTM
$510M
$21K ﹤0.01%
818
+568
+227% +$14.4K
XTLB
5897
XTL Biopharmaceuticals
XTLB
$6.93M
$21K ﹤0.01%
1,665
+275
+20% +$2.91K
PENG
5898
Penguin Solutions Inc
PENG
$2.7B
$21K ﹤0.01%
+2,600
New +$19.7K
ACCS
5899
ACCESS Newswire
ACCS
$26.4M
$21K ﹤0.01%
1,694
+1,194
+239% +$14.6K
AMBC.WS
5900
DELISTED
Ambac Financial Group
AMBC.WS
$21K ﹤0.01%
2,502

Similar funds

Morgan Stanley's Q2 2017 Portfolio in Review

As of Q2 2017, Morgan Stanley held 6,874 positions worth $331B, up 1.7% from $325B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Morgan Stanley's Q2 2017 filing shows 204 new, 2,959 increased, 3,018 reduced and 165 closed positions. Its largest new stake was Altaba Inc: 6,949,032 shares worth $379M. The largest sale was iShares Russell 2000 ETF, an estimated $1.9B.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

  • Morgan Stanley's largest Q2 2017 buy was Altaba Inc: 6,949,032 shares worth $379M.
  • Morgan Stanley added most to Starbucks in Q2 2017, an estimated $500M increase.
  • Morgan Stanley's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.9B.
  • Morgan Stanley fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $539M.
  • Morgan Stanley's ten largest holdings make up 12% of its $331B portfolio in Q2 2017.
  • Morgan Stanley opened 204 new positions and closed 165 in Q2 2017.
  • Morgan Stanley's portfolio value rose 1.7% quarter-over-quarter to $331B.

Based on Morgan Stanley's 13F filing for Q2 2017, filed 11 Aug 2017.